| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $34.30B | $30.13B | $29.14B | $28.50B | $27.78B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $2.52B | $2.25B | $2.35B | $2.04B | $1.98B |
| SG&A | $5.70B | $4.87B | $5.16B | $4.94B | $4.93B |
| Operating Income | -$437.00M | $2.19B | $2.09B | $782.00M | $1.13B |
| Interest Expense | $1.10B | $777.00M | $709.00M | $471.00M | $501.00M |
| Tax Expense | -$342.00M | $374.00M | $205.00M | $8.00M | $160.00M |
| Net Income | $57.00M | $2.58B | $2.02B | $868.00M | $3.43B |
| EPS (basic) | -0.0400 | 1.9500 | 1.5600 | 0.6700 | 2.6200 |
| EPS (diluted) | -0.0400 | 1.9300 | 1.5400 | 0.6600 | 2.5800 |
| Shares (diluted) | $1.32B | $1.34B | $1.32B | $1.32B | $1.33B |